BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34782396)

  • 1. Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives.
    Antwi SO; Rabe KG; Bamlet WR; Meyer M; Chandra S; Fagan SE; Hu C; Couch FJ; McWilliams RR; Oberg AL; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):372-381. PubMed ID: 34782396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status.
    Antwi SO; Fagan SE; Chaffee KG; Bamlet WR; Hu C; Polley EC; Hart SN; Shimelis H; Lilyquist J; Gnanaolivu RD; McWilliams RR; Oberg AL; Couch FJ; Petersen GM
    J Natl Cancer Inst; 2019 Mar; 111(3):264-271. PubMed ID: 29982661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
    Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
    JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.
    Mukherjee B; Delancey JO; Raskin L; Everett J; Jeter J; Begg CB; Orlow I; Berwick M; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Culver HA; Rosso S; Zanetti R; Kanetsky PA; From L; Gruber SB;
    J Natl Cancer Inst; 2012 Jun; 104(12):953-6. PubMed ID: 22534780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
    Seven M; Shah LL; Yazici H; Daack-Hirsch S
    Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.
    Arora-Singh RK; Assassi S; del Junco DJ; Arnett FC; Perry M; Irfan U; Sharif R; Mattar T; Mayes MD
    J Autoimmun; 2010 Aug; 35(1):52-7. PubMed ID: 20223638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer risk to siblings of probands in bilineal cancer settings.
    Rabe KG; Stevens MA; Hernández AT; Chandra S; Hubbard JM; Kemppainen JL; Majumder S; Petersen GM
    Genet Med; 2022 May; 24(5):1008-1016. PubMed ID: 35227607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group and the risk of pancreatic cancer.
    Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
    J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial pancreatic cancer risk: a population-based study in Utah.
    Kohli DR; Smith KR; Wong J; Yu Z; Boucher K; Faigel DO; Pannala R; Burt RW; Curtin K; Samadder NJ
    J Gastroenterol; 2019 Dec; 54(12):1106-1112. PubMed ID: 31240435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.
    Risch HA; Lu L; Wang J; Zhang W; Ni Q; Gao YT; Yu H
    Am J Epidemiol; 2013 Jun; 177(12):1326-37. PubMed ID: 23652164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
    Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
    Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.
    McWilliams RR; Rabe KG; Olswold C; De Andrade M; Petersen GM
    Cancer; 2005 Jul; 104(2):388-94. PubMed ID: 15912495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
    Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
    Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
    El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
    Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer risk based on extended family history and body mass index.
    Ochs-Balcom HM; Kanth P; Farnham JM; Abdelrahman S; Cannon-Albright LA
    Genet Epidemiol; 2020 Oct; 44(7):778-784. PubMed ID: 32677164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
    Wolpin BM; Kraft P; Xu M; Steplowski E; Olsson ML; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Stolzenberg-Solomon RZ; Zheng W; Albanes D; Allen NE; Amundadottir L; Austin MA; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Sanchéz MJ; Sansbury L; Shu XO; Slimani N; Tobias GS; Trichopoulos D; Vineis P; Visvanathan K; Virtamo J; Wactawski-Wende J; Watters J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3140-9. PubMed ID: 20971884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant association between ABO blood group and pancreatic cancer.
    Greer JB; Yazer MH; Raval JS; Barmada MM; Brand RE; Whitcomb DC
    World J Gastroenterol; 2010 Nov; 16(44):5588-91. PubMed ID: 21105191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empowering Family Glaucoma Risk Communication Using QR-Code-Mediated Online Intervention.
    Hallaj S; Shah SJ; Cehelyk EK; Hock LE; Lee D; Razeghinejad R; Myers JS; Frasso R; Kolomeyer NN
    Ophthalmol Glaucoma; 2024; 7(2):190-196. PubMed ID: 37838087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cancer mortality in the relatives of patients with pancreatic cancer.
    Wang L; Brune KA; Visvanathan K; Laheru D; Herman J; Wolfgang C; Schulick R; Cameron JL; Goggins M; Hruban RH; Klein AP
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2829-34. PubMed ID: 19843679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.